Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia

Schizophrenia Research

Volumn 146, Issue 1-3, 2013, Pages 177-183

  Tucholski, Janusz ^a   Simmons, Micah S ^a   Pinner, Anita L ^a   Haroutunian, Vahram ^b   McCullumsmith, Robert E ^a   Meador Woodruff, James H ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Glutamate receptors; Postmortem brain; Prefrontal cortex; Psychosis

Indexed keywords

AMPA RECEPTOR; CONCANAVALIN A; ENDOGLYCOSIDASE H; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 4; GLUTAMIC ACID; GLYCOPEPTIDASE; GLYCOSIDASE; MANNOSE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DEGLYCOSYLATION; ENDOPLASMIC RETICULUM; ENZYME DEGRADATION; FEMALE; GOLGI COMPLEX; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NEUROTRANSMISSION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; SCHIZOPHRENIA; SYNAPTIC MEMBRANE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CONCANAVALIN A; FEMALE; GLYCOSYLATION; HUMANS; MALE; MANNOSYL-GLYCOPROTEIN ENDO-BETA-N-ACETYLGLUCOSAMINIDASE; MIDDLE AGED; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PREFRONTAL CORTEX; PROTEIN BINDING; PROTEIN SUBUNITS; RECEPTORS, AMPA; SCHIZOPHRENIA;

EID: 84875927147     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.01.031     Document Type: Article

References (47)

1. Akbarian S., Smith M.A., Jones E.G. Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia. Brain Res. 1995, 699(2):297-304.
2. Bauer D., Gupta D., Harotunian V., Meador-Woodruff J.H., McCullumsmith R.E. Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr. Res. 2008, 104(1-3):108-120.
3. Bauer D.E., Haroutunian V., McCullumsmith R.E., Meador-Woodruff J.H. Expression of four housekeeping proteins in elderly patients with schizophrenia. J. Neural Transm. 2009, 116(4):487-491.
4. Bauer D., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia. Schizophr. Res. 2010, 117(1):92-98.
5. Beneyto M., Meador-Woodruff J.H. Expression of transcripts encoding AMPA receptor subunits and associated postsynaptic proteins in the macaque brain. J. Comp. Neurol. 2004, 468(4):530-554.
6. Beneyto M., Meador-Woodruff J.H. Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia. Synapse 2006, 60(8):585-598.
7. Bowie D., Garcia E.P., Marshall J., Traynelis S.F., Lange G.D. Allosteric regulation and spatial distribution of kainate receptors bound to ancillary proteins. J. Physiol. 2003, 547(2):373-385.
8. Breese C.R., Freedman R., Leonard S.S. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res. 1995, 674(1):82-90.
9. Clark R.A., Gurd J.W., Bissoon N., Tricaud N., Molnar E., Zamze S.E., Dwek R.A., McIlhinney R.A., Wing D.R. Identification of lectin-purified neural glycoproteins, GPs 180, 116, and 110, with NMDA and AMPA receptor subunits: conservation of glycosylation at the synapse. J. Neurochem. 1998, 70(6):2594-2605.
10. Corti C., Xuereb J.H., Crepaldi L., Corsi M., Michielin F., Ferraguti F. Altered levels of glutamatergic receptors and Na+/K+ATPase-alpha1 in the prefrontal cortex of subjects with schizophrenia. Schizophr. Res. 2011, 128(1-3):7-14.
11. Cummings R.D. [6] Use of lectins in analysis of glycoconjugates. William J. Lennarz, G.W.H 1994, 66-86. Academic Press.
12. Davidson M., Harvey P.D., Powchik P., Parrella M., White L., Knobler H.Y., Losonczy M.F., Keefe R.S., Katz S., Frecska E. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am. J. Psychiatry 1995, 152(2):197-207.
13. Deakin J.F., Slater P., Simpson M.D., Gilchrist A.C., Skan W.J., Royston M.C., Reynolds G.P., Cross A.J. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 1989, 52(6):1781-1786.
14. Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 1999, 51(1):7-61.
15. Dracheva S., McGurk S.R., Haroutunian V. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics. J. Neurosci. Res. 2005, 79(6):868-878.
16. Drummond J.B., Simmons M., Haroutunian V., Meador-Woodruff J.H. Upregulation of cornichon transcripts in the dorsolateral prefrontal cortex in schizophrenia. Neuroreport 2012, 23(17):1031-1034.
17. Eastwood S.L., McDonald B., Burnet P.W., Beckwith J.P., Kerwin R.W., Harrison P.J. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res. Mol. Brain Res. 1995, 29(2):211-223.
18. Eastwood S.L., Burnet P.W.J., Harrison P.J. GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study. Mol. Brain Res. 1997, 44(1):92-98.
19. Eastwood S.L., Kerwin R.W., Harrison P.J. Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-d-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol. Psychiatry 1997, 41(6):636-643.
20. Everts I., Villmann C., Hollmann M. N-Glycosylation is not a prerequisite for glutamate receptor function but Is essential for lectin modulation. Mol. Pharmacol. 1997, 52(5):861-873.
21. Funk A.J., Rumbaugh G., Harotunian V., McCullumsmith R.E., Meador-Woodruff J.H. Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia. Neuroreport 2009, 20(11):1019-1022.
22. Greger I.H., Khatri L., Ziff E.B. RNA editing at arg607 controls AMPA receptor exit from the endoplasmic reticulum. Neuron 2002, 34(5):759-772.
23. Greger I.H., Khatri L., Kong X., Ziff E.B. AMPA receptor tetramerization is mediated by Q/R editing. Neuron 2003, 40(4):763-774.
24. Hammond J.C., McCullumsmith R.E., Funk A.J., Haroutunian V., Meador-Woodruff J.H. Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia. Neuropsychopharmacology 2010, 35(10):2110-2119.
25. Hammond J.C., McCullumsmith R.E., Haroutunian V., Meador-Woodruff J.H. Endosomal trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia. Schizophr. Res. 2011, 130(1-3):260-265.
26. Harvey P.D., Davidson M., Powchik P., Parrella M., White L., Mohs R.C. Assessment of dementia in elderly schizophrenics with structured rating scales. Schizophr. Res. 1992, 7(1):85-90.
27. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 1991, 148(10):1301-1308.
28. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999, 20(3):201-225.
29. Kaplan H.A., Welply J.K., Lennarz W.J. Oligosaccharyl transferase: the central enzyme in the pathway of glycoprotein assembly. Biochim. Biophys. Acta Rev. Biomembr. 1987, 906(2):161-173.
30. Kerwin R.W., Patel S., Meldrum B.S., Czudek C., Reynolds G.P. Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia. Lancet 1988, 1(8585):583-584.
31. Kerwin R., Patel S., Meldrum B. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience 1990, 39(1):25-32.
32. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 1994, 51(3):199-214.
33. Madden D.R. The structure and function of glutamate receptor ion channels. Nat. Rev. Neurosci. 2002, 3(2):91-101.
34. Mathers D.A., Usherwood P.N. Concanavalin A blocks desensitisation of glutamate receptors on insect muscle fibres. Nature 1976, 259(5542):409-411.
35. Meador-Woodruff J.H., Hogg A.J., Smith R.E. Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder. Brain Res. Bull. 2001, 55(5):631-640.
36. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000, 28(1):53-67.
37. Nishikawa T., Takashima M., Toru M. Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia. Neurosci. Lett. 1983, 40(3):245-250.
38. O'Connor J.A., Muly E.C., Arnold S.E., Hemby S.E. AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs. Schizophr. Res. 2007, 90(1-3):28-40.
39. Page K.J., Everitt B.J. The distribution of neurons coexpressing immunoreactivity to AMPA-sensitive glutamate receptor subtypes (GluR1-4) and nerve growth factor receptor in the rat basal forebrain. Eur. J. Neurosci. 1995, 7(5):1022-1033.
40. Powchik P., Davidson M., Haroutunian V., Gabriel S.M., Purohit D.P., Perl D.P., Harvey P.D., Davis K.L. Postmortem studies in schizophrenia. Schizophr. Bull. 1998, 24(3):325-341.
41. Silberstein S., Gilmore R. Biochemistry, molecular biology, and genetics of the oligosaccharyltransferase. FASEB J. 1996, 10(8):849-858.
42. Tamminga C. Glutamatergic aspects of schizophrenia. Br. J. Psychiatry Suppl. 1999, (37):12-15.
43. Tomita S. Regulation of ionotropic glutamate receptors by their auxiliary subunits. Physiology 2010, 25(1):41-49.
44. Toyooka K., Iritani S., Makifuchi T., Shirakawa O., Kitamura N., Maeda K., Nakamura R., Niizato K., Watanabe M., Kakita A., Takahashi H., Someya T., Nawa H. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J. Neurochem. 2002, 83(4):797-806.
45. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 2002, 42:165-179.
46. Vandenberghe W., Bredt D.S. Early events in glutamate receptor trafficking. Curr. Opin. Cell Biol. 2004, 16(2):134-139.
47. Ziff E.B. TARPs and the AMPA receptor trafficking paradox. Neuron 2007, 53(5):627-633.